Modulation of NK3.3 cytotoxic activity by selenium compounds

Randall Davis, R. Rodrisuez, Y. Lu, C. A. Phillips, J. E. Spallholz

Research output: Contribution to journalArticle

Abstract

Selenium (Se) has been well documented as a modulator of natural killer (NK) cell function, however, the immunomodulatory mechanism(s) by which Se functions is not well understood. Previous in vitro studies on the effect of Se on NK cell function used mixed lymphocyte populations or enriched NK cell populations from peripheral blood or spleen. To alleviate extraneous variables, we assessed the effects of Se compounds on the cytotoxic activity of a human, non-transformed, NK cell line (NK3.3) derived from a mixed lymphocyte culture from normal donors. Phenotypically, the NK3.3 cell tine is CD2, CD3 , CD4-, CDS , CD16(FcYRIIIA), CD38, CD45, CD56 HLA-DR', -DP, DQ, Leu7, does not produce transcripts for the a, , or y chains of the TCR , and is 1L-2 dependent (J. Kornbluth, Univ. of Arkansas, Little Rock, AR). NK3.3 cells were treated overnight (18 hr) with 0 - 2.5 u.g Se/ml as sodium selenite (Na2SeO3) or selenomethionine (SeMet). Following Se treatment, NK3.3 cells were assessed for antibody-dependent-cell-cytotoxicity (ADCC) against Raji cells, natural cytotoxicity against K562 cells, granule release (serine esterase activity), and CD16 cell surface receptor expression. The data indicate Na2SeO3 decreases NK3.3 ADCC and natural cytotoxicity dose-dependently, whereas SeMet had no effect. Neither NK3.3 serine esterase activity nor CD 16 receptor expression on NK3.3 cells were affected by Na2SeOj or SeMet. These results suggest NajSeO, is a more effective modulator of NK3.3 cytotoxicity than SeMet and the mechanism(s) by which Se suppresses cytotoxicity is not related to granule release or CD16 receptor expression. Other steps in the signal transduction pathway are being investigated.

Original languageEnglish
JournalFASEB Journal
Volume10
Issue number6
StatePublished - 1 Dec 1996

Fingerprint

Selenium Compounds
Cytotoxicity
Selenium
Selenomethionine
Modulation
Natural Killer Cells
Antibody-Dependent Cell Cytotoxicity
Lymphocytes
Modulators
HLA-DP Antigens
Cells
Sodium Selenite
Signal transduction
K562 Cells
Antibodies
Cell Surface Receptors
HLA-DR Antigens
Cell culture
Human Activities
Population

Cite this

Davis, R., Rodrisuez, R., Lu, Y., Phillips, C. A., & Spallholz, J. E. (1996). Modulation of NK3.3 cytotoxic activity by selenium compounds. FASEB Journal, 10(6).
Davis, Randall ; Rodrisuez, R. ; Lu, Y. ; Phillips, C. A. ; Spallholz, J. E. / Modulation of NK3.3 cytotoxic activity by selenium compounds. In: FASEB Journal. 1996 ; Vol. 10, No. 6.
@article{6e3b0a0faeb74f179e4494d0af45f548,
title = "Modulation of NK3.3 cytotoxic activity by selenium compounds",
abstract = "Selenium (Se) has been well documented as a modulator of natural killer (NK) cell function, however, the immunomodulatory mechanism(s) by which Se functions is not well understood. Previous in vitro studies on the effect of Se on NK cell function used mixed lymphocyte populations or enriched NK cell populations from peripheral blood or spleen. To alleviate extraneous variables, we assessed the effects of Se compounds on the cytotoxic activity of a human, non-transformed, NK cell line (NK3.3) derived from a mixed lymphocyte culture from normal donors. Phenotypically, the NK3.3 cell tine is CD2, CD3 , CD4-, CDS , CD16(FcYRIIIA), CD38, CD45, CD56 HLA-DR', -DP, DQ, Leu7, does not produce transcripts for the a, , or y chains of the TCR , and is 1L-2 dependent (J. Kornbluth, Univ. of Arkansas, Little Rock, AR). NK3.3 cells were treated overnight (18 hr) with 0 - 2.5 u.g Se/ml as sodium selenite (Na2SeO3) or selenomethionine (SeMet). Following Se treatment, NK3.3 cells were assessed for antibody-dependent-cell-cytotoxicity (ADCC) against Raji cells, natural cytotoxicity against K562 cells, granule release (serine esterase activity), and CD16 cell surface receptor expression. The data indicate Na2SeO3 decreases NK3.3 ADCC and natural cytotoxicity dose-dependently, whereas SeMet had no effect. Neither NK3.3 serine esterase activity nor CD 16 receptor expression on NK3.3 cells were affected by Na2SeOj or SeMet. These results suggest NajSeO, is a more effective modulator of NK3.3 cytotoxicity than SeMet and the mechanism(s) by which Se suppresses cytotoxicity is not related to granule release or CD16 receptor expression. Other steps in the signal transduction pathway are being investigated.",
author = "Randall Davis and R. Rodrisuez and Y. Lu and Phillips, {C. A.} and Spallholz, {J. E.}",
year = "1996",
month = "12",
day = "1",
language = "English",
volume = "10",
journal = "FASEB Journal",
issn = "0892-6638",
publisher = "FASEB",
number = "6",

}

Davis, R, Rodrisuez, R, Lu, Y, Phillips, CA & Spallholz, JE 1996, 'Modulation of NK3.3 cytotoxic activity by selenium compounds', FASEB Journal, vol. 10, no. 6.

Modulation of NK3.3 cytotoxic activity by selenium compounds. / Davis, Randall; Rodrisuez, R.; Lu, Y.; Phillips, C. A.; Spallholz, J. E.

In: FASEB Journal, Vol. 10, No. 6, 01.12.1996.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Modulation of NK3.3 cytotoxic activity by selenium compounds

AU - Davis, Randall

AU - Rodrisuez, R.

AU - Lu, Y.

AU - Phillips, C. A.

AU - Spallholz, J. E.

PY - 1996/12/1

Y1 - 1996/12/1

N2 - Selenium (Se) has been well documented as a modulator of natural killer (NK) cell function, however, the immunomodulatory mechanism(s) by which Se functions is not well understood. Previous in vitro studies on the effect of Se on NK cell function used mixed lymphocyte populations or enriched NK cell populations from peripheral blood or spleen. To alleviate extraneous variables, we assessed the effects of Se compounds on the cytotoxic activity of a human, non-transformed, NK cell line (NK3.3) derived from a mixed lymphocyte culture from normal donors. Phenotypically, the NK3.3 cell tine is CD2, CD3 , CD4-, CDS , CD16(FcYRIIIA), CD38, CD45, CD56 HLA-DR', -DP, DQ, Leu7, does not produce transcripts for the a, , or y chains of the TCR , and is 1L-2 dependent (J. Kornbluth, Univ. of Arkansas, Little Rock, AR). NK3.3 cells were treated overnight (18 hr) with 0 - 2.5 u.g Se/ml as sodium selenite (Na2SeO3) or selenomethionine (SeMet). Following Se treatment, NK3.3 cells were assessed for antibody-dependent-cell-cytotoxicity (ADCC) against Raji cells, natural cytotoxicity against K562 cells, granule release (serine esterase activity), and CD16 cell surface receptor expression. The data indicate Na2SeO3 decreases NK3.3 ADCC and natural cytotoxicity dose-dependently, whereas SeMet had no effect. Neither NK3.3 serine esterase activity nor CD 16 receptor expression on NK3.3 cells were affected by Na2SeOj or SeMet. These results suggest NajSeO, is a more effective modulator of NK3.3 cytotoxicity than SeMet and the mechanism(s) by which Se suppresses cytotoxicity is not related to granule release or CD16 receptor expression. Other steps in the signal transduction pathway are being investigated.

AB - Selenium (Se) has been well documented as a modulator of natural killer (NK) cell function, however, the immunomodulatory mechanism(s) by which Se functions is not well understood. Previous in vitro studies on the effect of Se on NK cell function used mixed lymphocyte populations or enriched NK cell populations from peripheral blood or spleen. To alleviate extraneous variables, we assessed the effects of Se compounds on the cytotoxic activity of a human, non-transformed, NK cell line (NK3.3) derived from a mixed lymphocyte culture from normal donors. Phenotypically, the NK3.3 cell tine is CD2, CD3 , CD4-, CDS , CD16(FcYRIIIA), CD38, CD45, CD56 HLA-DR', -DP, DQ, Leu7, does not produce transcripts for the a, , or y chains of the TCR , and is 1L-2 dependent (J. Kornbluth, Univ. of Arkansas, Little Rock, AR). NK3.3 cells were treated overnight (18 hr) with 0 - 2.5 u.g Se/ml as sodium selenite (Na2SeO3) or selenomethionine (SeMet). Following Se treatment, NK3.3 cells were assessed for antibody-dependent-cell-cytotoxicity (ADCC) against Raji cells, natural cytotoxicity against K562 cells, granule release (serine esterase activity), and CD16 cell surface receptor expression. The data indicate Na2SeO3 decreases NK3.3 ADCC and natural cytotoxicity dose-dependently, whereas SeMet had no effect. Neither NK3.3 serine esterase activity nor CD 16 receptor expression on NK3.3 cells were affected by Na2SeOj or SeMet. These results suggest NajSeO, is a more effective modulator of NK3.3 cytotoxicity than SeMet and the mechanism(s) by which Se suppresses cytotoxicity is not related to granule release or CD16 receptor expression. Other steps in the signal transduction pathway are being investigated.

UR - http://www.scopus.com/inward/record.url?scp=33749149037&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:33749149037

VL - 10

JO - FASEB Journal

JF - FASEB Journal

SN - 0892-6638

IS - 6

ER -

Davis R, Rodrisuez R, Lu Y, Phillips CA, Spallholz JE. Modulation of NK3.3 cytotoxic activity by selenium compounds. FASEB Journal. 1996 Dec 1;10(6).